1316 related articles for article (PubMed ID: 21304099)
1. Interleukin-1 in the pathogenesis and treatment of inflammatory diseases.
Dinarello CA
Blood; 2011 Apr; 117(14):3720-32. PubMed ID: 21304099
[TBL] [Abstract][Full Text] [Related]
2. The interleukin-1 receptor family.
Boraschi D; Tagliabue A
Semin Immunol; 2013 Dec; 25(6):394-407. PubMed ID: 24246227
[TBL] [Abstract][Full Text] [Related]
3. An expanding role for interleukin-1 blockade from gout to cancer.
Dinarello CA
Mol Med; 2014 Dec; 20 Suppl 1(Suppl 1):S43-58. PubMed ID: 25549233
[TBL] [Abstract][Full Text] [Related]
4. Immunological and inflammatory functions of the interleukin-1 family.
Dinarello CA
Annu Rev Immunol; 2009; 27():519-50. PubMed ID: 19302047
[TBL] [Abstract][Full Text] [Related]
5. Overview of the interleukin-1 family of ligands and receptors.
Dinarello CA
Semin Immunol; 2013 Dec; 25(6):389-93. PubMed ID: 24275600
[TBL] [Abstract][Full Text] [Related]
6. Blocking interleukin-1β in acute and chronic autoinflammatory diseases.
Dinarello CA
J Intern Med; 2011 Jan; 269(1):16-28. PubMed ID: 21158974
[TBL] [Abstract][Full Text] [Related]
7. [IL-1 family (IL-1alpha/beta, IL-1Ra, IL-18), IL-16, IL-17].
Okamura H
Nihon Rinsho; 2005 Apr; 63 Suppl 4():226-33. PubMed ID: 15861661
[No Abstract] [Full Text] [Related]
8. The interleukin (IL)-1 cytokine family--Balance between agonists and antagonists in inflammatory diseases.
Palomo J; Dietrich D; Martin P; Palmer G; Gabay C
Cytokine; 2015 Nov; 76(1):25-37. PubMed ID: 26185894
[TBL] [Abstract][Full Text] [Related]
9. Overview of the IL-1 family in innate inflammation and acquired immunity.
Dinarello CA
Immunol Rev; 2018 Jan; 281(1):8-27. PubMed ID: 29247995
[TBL] [Abstract][Full Text] [Related]
10. An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist.
Aksentijevich I; Masters SL; Ferguson PJ; Dancey P; Frenkel J; van Royen-Kerkhoff A; Laxer R; Tedgård U; Cowen EW; Pham TH; Booty M; Estes JD; Sandler NG; Plass N; Stone DL; Turner ML; Hill S; Butman JA; Schneider R; Babyn P; El-Shanti HI; Pope E; Barron K; Bing X; Laurence A; Lee CC; Chapelle D; Clarke GI; Ohson K; Nicholson M; Gadina M; Yang B; Korman BD; Gregersen PK; van Hagen PM; Hak AE; Huizing M; Rahman P; Douek DC; Remmers EF; Kastner DL; Goldbach-Mansky R
N Engl J Med; 2009 Jun; 360(23):2426-37. PubMed ID: 19494218
[TBL] [Abstract][Full Text] [Related]
11. The interleukin-1 receptor/Toll-like receptor superfamily: signal transduction during inflammation and host defense.
Dunne A; O'Neill LA
Sci STKE; 2003 Feb; 2003(171):re3. PubMed ID: 12606705
[TBL] [Abstract][Full Text] [Related]
12. Cytokines of the IL-1 family: recognized targets in chronic inflammation underrated in organ transplantations.
Striz I
Clin Sci (Lond); 2017 Sep; 131(17):2241-2256. PubMed ID: 28798075
[TBL] [Abstract][Full Text] [Related]
13. Treating rheumatological diseases and co-morbidities with interleukin-1 blocking therapies.
Cavalli G; Dinarello CA
Rheumatology (Oxford); 2015 Dec; 54(12):2134-44. PubMed ID: 26209330
[TBL] [Abstract][Full Text] [Related]
14. The IL-1 family of cytokines and receptors in rheumatic diseases.
Dinarello CA
Nat Rev Rheumatol; 2019 Oct; 15(10):612-632. PubMed ID: 31515542
[TBL] [Abstract][Full Text] [Related]
15. Toll-like receptor 2 pathway drives streptococcal cell wall-induced joint inflammation: critical role of myeloid differentiation factor 88.
Joosten LA; Koenders MI; Smeets RL; Heuvelmans-Jacobs M; Helsen MM; Takeda K; Akira S; Lubberts E; van de Loo FA; van den Berg WB
J Immunol; 2003 Dec; 171(11):6145-53. PubMed ID: 14634130
[TBL] [Abstract][Full Text] [Related]
16. A clinical perspective of IL-1β as the gatekeeper of inflammation.
Dinarello CA
Eur J Immunol; 2011 May; 41(5):1203-17. PubMed ID: 21523780
[TBL] [Abstract][Full Text] [Related]
17. IL-37 As a Potential Biotherapeutics of Inflammatory Diseases.
Bai J; Li Y; Li M; Tan S; Wu D
Curr Drug Targets; 2020; 21(9):855-863. PubMed ID: 32348214
[TBL] [Abstract][Full Text] [Related]
18. Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases.
Dinarello CA; Simon A; van der Meer JW
Nat Rev Drug Discov; 2012 Aug; 11(8):633-52. PubMed ID: 22850787
[TBL] [Abstract][Full Text] [Related]
19. MyD88-dependent and -independent signaling by IL-1 in neurons probed by bifunctional Toll/IL-1 receptor domain/BB-loop mimetics.
Davis CN; Mann E; Behrens MM; Gaidarova S; Rebek M; Rebek J; Bartfai T
Proc Natl Acad Sci U S A; 2006 Feb; 103(8):2953-8. PubMed ID: 16477040
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-1beta and the autoinflammatory diseases.
Dinarello CA
N Engl J Med; 2009 Jun; 360(23):2467-70. PubMed ID: 19494224
[No Abstract] [Full Text] [Related]
[Next] [New Search]
